CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Proteomics
  • Top Proteomics Solutions Companies

Proteomics 2022

Top 10 Proteomics Solutions Companies 2022

Top 10 Proteomics Solutions Companies 2022

Proteomics is often used in clinical research as a tool for exploring cellular pathways and disease processes. Clinical proteomics can be divided into two areas: expression proteomics and functional proteomics. Expression proteomics compares the differential expression between proteomes of cells, tissues, or organisms to a control proteome in an experimental condition. Functional proteomics explores how protein modifications and interactions affect protein function during physiological and pathological conditions.

Information about the protein that may be useful in the study of proteomics includes the affluence, variations, alterations and partners or networks of the protein being studied. These findings can help to improve our understanding of the structure, function and interactions of all of the proteins that exist within a specific organism.

Over the past decade, technological advances in mass spectrometry and bioinformatics have facilitated novel applications of clinical proteomics in biomarker discovery, drug development, and disease etiology.

Technical advances in mass spectrometry and machine learning promise to transform personalized medicine. However, challenges in sample preparation and lack of standardization of the analytical procedures and workflows hamper widespread use of mass spectrometry in clinical laboratories. Unless these challenges are addressed, proteomics will continue to be used as a preclinical hypothesis-generating tool instead of a widely accepted clinical diagnostic.

It is important for proteomics research to focus on the behaviour of proteins in a real life environment and for each study to be considered in the context of its environment. At present, in the field of proteomics, the environmental context is not well addressed, despite its importance. This is expected to have greater priority as the study of proteomics progresses. For example, the increasing use of chemical cross-linkers in proteomics may help to improve this issue.

The proteome of human plasma holds insight about the physiological wellbeing of all other tissues within the body and is easily accessible for testing from individuals. Therefore, if the proteome can be established the information would be invaluable for medical purposes and could potentially be used as a diagnostic tool for a wide range of health conditions.

Let us know your thoughts.  

Top 10 Proteomics Solutions Companies 2022

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Proteomics Solutions Companies

    ★Featured Companies
    Biodesix, Inc. (NASDAQ: BDSX)
    Biodesix, Inc. (NASDAQ: BDSX)
    Read full profile →
    Biodesix, Inc. is a market leader with over 15 years of experience in the field of clinical proteomics. The company is an expert at profiling the patient's immune response to their cancer with blood-based proteomic solutions in addition to traditional genomic insights. Its technologies and machine learning expertise allow for identifying clinically relevant proteomic differences in patient populations to help guide treatment strategy ... read full profile
    Applied Biomics
    Applied Biomics
    Applied Biomics is a Proteomics Service company dedicated to providing top-quality, cost-effective and full-line proteomics services to meet their customers' research and discovery needs. They cover both major platforms of proteomics: gel-based 2D DIGE (2-dimensional differential in-gel electrophoresis) and liquid-based iTRAQ® (isobaric tags for relative and absolute quantitation)
    Arbor Vita
    Arbor Vita
    Arbor Vita is committed to making a difference by enabling early and accurate diagnosis and treatment of disease. The company has products on the market or in clinical studies to address global health challenges in the areas of HPV-induced cancer and infectious disease. AVC also has a pipeline of products in development
    Biosero
    Biosero
    Biosero develops science-centric software and laboratory automation tools that enable researchers to orchestrate their discoveries at every stage. Their Green Button Go software and integration services match laboratory automation to science, creating a cohesive technology ecosystem that accelerates operations and increases productivity
    BPS Bioscience
    BPS Bioscience
    BPS Bioscience manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, biochemical and cellular assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products. BPS Bioscience also provides custom protein expression, biochemical and cell-based assays, cell line development, CRISPR, BLI and compound screening services
    Covaris
    Covaris
    Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process. The Covaris technological foundation is based on its proprietary and patented AFA™ technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in Genomics, Proteomics, Cell Biology and Drug Discovery, and Formulation
    Integral Molecular
    Integral Molecular
    Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, and transporters. The Company has over a decade of experience in optimizing membrane proteins, enabling the isolation, characterization, and engineering of monoclonal antibodies against otherwise intractable membrane protein targets
    Neoleukin Therapeutics
    Neoleukin Therapeutics
    Neoleukin Therapeutics is creating next generation immunotherapies using breakthrough de novo protein design technology. They use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties
    Plexium
    Plexium
    Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and cereblon. The company’s platform is a proprietary drug discovery platform designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation
    REGENXBIO
    REGENXBIO
    REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://proteomics.lifesciencesreview.com/vendors/top-proteomics-solution-companies.html